Synapse - David Straus

Results (356)

FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma

Meeting Abstract

Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
Blood (2013)

Fulltext@MSK | Save

Acupuncture for the treatment of post-chemotherapy chronic fatigue: A randomized, blinded, sham-controlled trial

Journal Article

Deng, G.; Chan, Y.; Sjoberg, D.; Vickers, A.; Yeung, K. S.; Kris, M.; Straus, D.; Cassileth, B.
Supportive Care in Cancer (2013)

Fulltext@MSK | Save

Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma

Journal Article

Moskowitz, A. J.; Hamlin, P. A. Jr; Perales, M. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M. J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies

Journal Article

Vijai, J.; Kirchhoff, T.; Schrader, K. A.; Brown, J.; Dutra Clarke, A. V.; Manschreck, C.; Hansen, N.; Rau-Murthy, R.; Sarrel, K.; Przybylo, J.; more...
PLoS Genetics (2013)

Fulltext@MSK | Save

Final results of phase I/II trial of vorinostat in combination with cyclophosphamide, etoposide, prednisone, and rituximab (R-CVEP) for elderly patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)

Meeting Abstract

Straus, D. J.; Hamlin, P. A.; Matasar, M. J.; Palomba, M. L.; Drullinsky, P.; Zelenetz, A. D.; Gerecitano, J. F.; Noy, A.; Hamilton, A. M.; Wegner, B.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placebo

Journal Article

Prince, H. M.; Duvic, M.; Martin, A.; Sterry, W.; Assaf, C.; Straus, D. J.
Journal of the American Academy of Dermatology (2012)

Fulltext@MSK | Save

CD30 is a potential therapeutic target in patients with HTLV-1 associated adult T-cell leukemia/lymphoma presenting outside of Japan

Meeting Abstract

Lunning, M. A.; Chiu, A.; Feldstein, J. T.; Maragulia, J. C.; Moskowitz, A.; Matasar, M. J.; Straus, D. J.; Noy, A.; Myskowski, P. L.; Zelenetz, A. D.; more...
Blood (2012)

Fulltext@MSK | Save

Clinical guidelines, the politics of value, and the practice of medicine: Physicians at the crossroads

Journal Article

Cooper, R. A.; Straus, D. J.
Journal of Oncology Practice (2012)

Fulltext@MSK | Save

Interim [18F]fluorodeoxyglucose positron emission tomography imaging in stage III non-bulky Hodgkin lymphoma: Would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?